Antti Haapalinna
R&d
Turku, Finland
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
In depth behavioral phenotyping unravels complex motor disturbances in Cstb-/- mouse, a model for progressive myoclonus epilepsy type 1.
Journal: Frontiers in behavioral neuroscience
Published: October 20, 2023
Tasipimidine-the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist.
Journal: European journal of pharmacology
Published: March 09, 2022
Effects of fadolmidine, an α2 -adrenoceptor agonist, as an adjuvant to spinal bupivacaine on antinociception and motor function in rats and dogs.
Journal: Pharmacology research & perspectives
Published: June 03, 2021
Fadolmidine - Favourable adverse effects profile for spinal analgesia suggested by in vitro and in vivo models.
Journal: European journal of pharmacology
Published: January 10, 2020
Pharmacodynamics of intrathecal and epidural fadolmidine, an α2-adrenoceptor agonist, after bolus and infusion in dogs-comparison with clonidine.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 26, 2019
Levosimendan alone and in combination with valsartan prevents stroke in Dahl salt-sensitive rats.
Journal: European journal of pharmacology
Published: October 03, 2014
Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
Journal: Basic & clinical pharmacology & toxicology
Published: February 10, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026